

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.77738200 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.15141215 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.84689291 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.80150608 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.80150608 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.41832323 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.41832323 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.04094503 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.70824544 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 6.21824550 |
| 11 | oxidative demethylation (GO:0070989) | 6.19276658 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.74169115 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.74169115 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.74169115 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68262638 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.67470198 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.63677527 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.57213720 |
| 19 | cysteine metabolic process (GO:0006534) | 5.56682842 |
| 20 | urea cycle (GO:0000050) | 5.54361286 |
| 21 | urea metabolic process (GO:0019627) | 5.54361286 |
| 22 | bile acid biosynthetic process (GO:0006699) | 5.49349669 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.46584236 |
| 24 | protein carboxylation (GO:0018214) | 5.46584236 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.45304536 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 5.44517027 |
| 27 | tryptophan metabolic process (GO:0006568) | 5.44511440 |
| 28 | glyoxylate metabolic process (GO:0046487) | 5.39897723 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.31968308 |
| 30 | reverse cholesterol transport (GO:0043691) | 5.27701539 |
| 31 | regulation of plasminogen activation (GO:0010755) | 5.18491499 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 5.15318251 |
| 33 | macromolecular complex remodeling (GO:0034367) | 5.15318251 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 5.15318251 |
| 35 | S-adenosylmethionine metabolic process (GO:0046500) | 5.11090939 |
| 36 | negative regulation of sterol transport (GO:0032372) | 5.10241352 |
| 37 | negative regulation of cholesterol transport (GO:0032375) | 5.10241352 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 5.09230469 |
| 39 | bile acid metabolic process (GO:0008206) | 5.05586653 |
| 40 | phospholipid efflux (GO:0033700) | 5.02558259 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.99982606 |
| 42 | protein activation cascade (GO:0072376) | 4.92877408 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.88932711 |
| 44 | ethanol metabolic process (GO:0006067) | 4.87705739 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.86288581 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.83330931 |
| 47 | phenylpropanoid metabolic process (GO:0009698) | 4.73515193 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.70166697 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.70166697 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.69406901 |
| 51 | low-density lipoprotein particle remodeling (GO:0034374) | 4.67462066 |
| 52 | complement activation (GO:0006956) | 4.66036214 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 4.64435086 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.63575067 |
| 55 | alkaloid metabolic process (GO:0009820) | 4.62607398 |
| 56 | homocysteine metabolic process (GO:0050667) | 4.58321654 |
| 57 | complement activation, classical pathway (GO:0006958) | 4.56479025 |
| 58 | glycine metabolic process (GO:0006544) | 4.55780833 |
| 59 | imidazole-containing compound metabolic process (GO:0052803) | 4.46732105 |
| 60 | drug catabolic process (GO:0042737) | 4.46495068 |
| 61 | cholesterol efflux (GO:0033344) | 4.44314566 |
| 62 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.43888618 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.43037763 |
| 64 | regulation of protein activation cascade (GO:2000257) | 4.37542608 |
| 65 | acute-phase response (GO:0006953) | 4.35626222 |
| 66 | regulation of humoral immune response (GO:0002920) | 4.33999833 |
| 67 | glutamate metabolic process (GO:0006536) | 4.33097729 |
| 68 | lysine catabolic process (GO:0006554) | 4.32306432 |
| 69 | lysine metabolic process (GO:0006553) | 4.32306432 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 4.32186988 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.31788893 |
| 72 | complement activation, alternative pathway (GO:0006957) | 4.31747889 |
| 73 | ketone body metabolic process (GO:1902224) | 4.23019168 |
| 74 | negative regulation of hemostasis (GO:1900047) | 4.21929954 |
| 75 | negative regulation of blood coagulation (GO:0030195) | 4.21929954 |
| 76 | cytolysis (GO:0019835) | 4.21888455 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.21479065 |
| 78 | cellular glucuronidation (GO:0052695) | 4.20611395 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 4.18097379 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.09652995 |
| 81 | indolalkylamine metabolic process (GO:0006586) | 4.08357364 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 4.07906169 |
| 83 | negative regulation of lipase activity (GO:0060192) | 4.07618612 |
| 84 | negative regulation of protein activation cascade (GO:2000258) | 4.07401107 |
| 85 | ethanol oxidation (GO:0006069) | 4.07218632 |
| 86 | coenzyme catabolic process (GO:0009109) | 4.06710203 |
| 87 | drug metabolic process (GO:0017144) | 4.06299589 |
| 88 | arginine metabolic process (GO:0006525) | 4.03997294 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 4.03899825 |
| 90 | amine catabolic process (GO:0009310) | 4.03899825 |
| 91 | aldehyde catabolic process (GO:0046185) | 4.01600830 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01349321 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 4.00194220 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.99854471 |
| 95 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.98612816 |
| 96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.98612816 |
| 97 | regulation of complement activation (GO:0030449) | 3.93961319 |
| 98 | protein-lipid complex assembly (GO:0065005) | 3.89242583 |
| 99 | fibrinolysis (GO:0042730) | 3.88737345 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.86472590 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.84650184 |
| 102 | negative regulation of coagulation (GO:0050819) | 3.83355739 |
| 103 | organic acid catabolic process (GO:0016054) | 3.81538788 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.81538788 |
| 105 | positive regulation of hemostasis (GO:1900048) | 3.81412018 |
| 106 | positive regulation of blood coagulation (GO:0030194) | 3.81412018 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.80717544 |
| 108 | flavonoid metabolic process (GO:0009812) | 3.78220474 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.75930858 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75918354 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75918354 |
| 112 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.75015749 |
| 113 | sterol homeostasis (GO:0055092) | 3.74383208 |
| 114 | negative regulation of wound healing (GO:0061045) | 3.74280466 |
| 115 | uronic acid metabolic process (GO:0006063) | 3.71826208 |
| 116 | glucuronate metabolic process (GO:0019585) | 3.71826208 |
| 117 | cofactor catabolic process (GO:0051187) | 3.65963285 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.65283833 |
| 119 | protein-lipid complex subunit organization (GO:0071825) | 3.64486445 |
| 120 | phospholipid homeostasis (GO:0055091) | 3.61797715 |
| 121 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59902382 |
| 122 | arginine catabolic process (GO:0006527) | 3.59727735 |
| 123 | opsonization (GO:0008228) | 3.58830378 |
| 124 | monocarboxylic acid catabolic process (GO:0072329) | 3.54787174 |
| 125 | lipoprotein metabolic process (GO:0042157) | 3.54504878 |
| 126 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.53263361 |
| 127 | intestinal cholesterol absorption (GO:0030299) | 3.47655700 |
| 128 | positive regulation of coagulation (GO:0050820) | 3.45456208 |
| 129 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.44558933 |
| 130 | peptidyl-glutamic acid modification (GO:0018200) | 3.40335881 |
| 131 | negative regulation of complement activation (GO:0045916) | 3.38285398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.46586189 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14469935 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.74607461 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.54834692 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.12722622 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.08676432 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.03197432 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.90032340 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87474336 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.20446226 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03792443 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7980826 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96115959 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85320315 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79540395 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78300981 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71598732 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65534623 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65037180 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60339555 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59583934 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56251250 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54469764 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53904963 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48533217 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45515057 |
| 27 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.38023942 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37204258 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33179390 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28628648 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27824270 |
| 32 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.23017881 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20578915 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18379232 |
| 35 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.18014029 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15701871 |
| 37 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15435024 |
| 38 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14935777 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14077595 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11553347 |
| 41 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10475483 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09693285 |
| 43 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09621082 |
| 44 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09621082 |
| 45 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08541051 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08541051 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07431827 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05622866 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05254723 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05254723 |
| 51 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05204730 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04171883 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03920699 |
| 54 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.02689278 |
| 55 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.02613427 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02598256 |
| 57 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.01054487 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00953621 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00865238 |
| 60 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99824756 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99286871 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99176996 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98893513 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98681888 |
| 65 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.97507935 |
| 66 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.95984738 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95826036 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94562606 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93455298 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92681195 |
| 71 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92651013 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92580971 |
| 73 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.92185298 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92045865 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91752233 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91436494 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91272801 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90915113 |
| 79 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89716196 |
| 80 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89139495 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89131957 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.89081794 |
| 83 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87455685 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87278698 |
| 85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85723314 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85487824 |
| 87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.85406166 |
| 88 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85054687 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84594810 |
| 90 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.84349045 |
| 91 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.82953899 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.82534883 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82532698 |
| 94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82333433 |
| 95 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82269816 |
| 96 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82044954 |
| 97 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.81711684 |
| 98 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81676585 |
| 99 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.81084644 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80711297 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.80404974 |
| 102 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79931679 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.79642486 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79642486 |
| 105 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79556695 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78755373 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72886173 |
| 108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72483231 |
| 109 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70827591 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.70335996 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69523241 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69037267 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68086245 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65925171 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63758697 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63647366 |
| 117 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62795198 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62159586 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61919660 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61919660 |
| 121 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61713247 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60290414 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59694731 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58505129 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.56552507 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.55542047 |
| 127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54637022 |
| 128 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53612452 |
| 129 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52597466 |
| 130 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51943068 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50766429 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47788980 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46949075 |
| 134 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.46944512 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46242609 |
| 136 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45322397 |
| 137 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45303906 |
| 138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45164350 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44468234 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44170071 |
| 141 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44169319 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43569154 |
| 143 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43159956 |
| 144 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43037534 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42964402 |
| 146 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.42330792 |
| 147 | AR_20517297_ChIP-Seq_VCAP_Human | 0.42216254 |
| 148 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.40963398 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.40000764 |
| 150 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39909661 |
| 151 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.39823007 |
| 152 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39092770 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.38079443 |
| 154 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.37647072 |
| 155 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.36836977 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36166704 |
| 157 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36081796 |
| 158 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.35527743 |
| 159 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.34593286 |
| 160 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34579197 |
| 161 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.34210739 |
| 162 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34156083 |
| 163 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33924024 |
| 164 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33914498 |
| 165 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.33901053 |
| 166 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.33693047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.56991599 |
| 2 | MP0005360_urolithiasis | 7.59142047 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.08788248 |
| 4 | MP0005365_abnormal_bile_salt | 6.02034518 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.38384985 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26074684 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.71057871 |
| 8 | MP0009840_abnormal_foam_cell | 3.67137785 |
| 9 | MP0003252_abnormal_bile_duct | 3.51930086 |
| 10 | MP0005083_abnormal_biliary_tract | 3.36681334 |
| 11 | MP0003195_calcinosis | 3.15913287 |
| 12 | MP0005332_abnormal_amino_acid | 2.78807132 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.41321494 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.19890128 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.12071498 |
| 16 | MP0000609_abnormal_liver_physiology | 2.11528041 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.11374662 |
| 18 | MP0005451_abnormal_body_composition | 1.93810244 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.77638050 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.76111492 |
| 21 | MP0009697_abnormal_copulation | 1.68750996 |
| 22 | MP0003868_abnormal_feces_composition | 1.68689375 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59982196 |
| 24 | MP0001764_abnormal_homeostasis | 1.59463695 |
| 25 | MP0000604_amyloidosis | 1.31689463 |
| 26 | MP0003011_delayed_dark_adaptation | 1.26376907 |
| 27 | MP0003186_abnormal_redox_activity | 1.24183404 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.23649088 |
| 29 | MP0006292_abnormal_olfactory_placode | 1.21220802 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.20890062 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.12060504 |
| 32 | MP0000598_abnormal_liver_morphology | 1.11542402 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.06997077 |
| 34 | MP0002282_abnormal_trachea_morphology | 1.05297549 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.02456200 |
| 36 | MP0009764_decreased_sensitivity_to | 1.01258959 |
| 37 | MP0005647_abnormal_sex_gland | 1.00848036 |
| 38 | MP0009763_increased_sensitivity_to | 1.00707957 |
| 39 | MP0005646_abnormal_pituitary_gland | 0.95628055 |
| 40 | MP0010368_abnormal_lymphatic_system | 0.94103426 |
| 41 | MP0002254_reproductive_system_inflammat | 0.92615107 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.88320997 |
| 43 | MP0009642_abnormal_blood_homeostasis | 0.87186733 |
| 44 | MP0003329_amyloid_beta_deposits | 0.86615328 |
| 45 | MP0005408_hypopigmentation | 0.85738286 |
| 46 | MP0003879_abnormal_hair_cell | 0.85604568 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.81724972 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.81594483 |
| 49 | MP0008469_abnormal_protein_level | 0.81333982 |
| 50 | MP0002132_abnormal_respiratory_system | 0.80094355 |
| 51 | MP0001661_extended_life_span | 0.79114999 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.77777957 |
| 53 | MP0003690_abnormal_glial_cell | 0.77514244 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.76775122 |
| 55 | MP0002971_abnormal_brown_adipose | 0.76609782 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 0.75677733 |
| 57 | MP0004142_abnormal_muscle_tone | 0.75584584 |
| 58 | MP0009053_abnormal_anal_canal | 0.74188703 |
| 59 | MP0009785_altered_susceptibility_to | 0.71348778 |
| 60 | MP0002638_abnormal_pupillary_reflex | 0.69401616 |
| 61 | MP0005334_abnormal_fat_pad | 0.69149280 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 0.67642249 |
| 63 | MP0004043_abnormal_pH_regulation | 0.65797125 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.65698251 |
| 65 | MP0005448_abnormal_energy_balance | 0.64381988 |
| 66 | MP0002822_catalepsy | 0.63250343 |
| 67 | MP0009745_abnormal_behavioral_response | 0.62397051 |
| 68 | MP0004130_abnormal_muscle_cell | 0.62380480 |
| 69 | MP0005535_abnormal_body_temperature | 0.60633167 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.60251730 |
| 71 | MP0005266_abnormal_metabolism | 0.59086452 |
| 72 | MP0001756_abnormal_urination | 0.58170627 |
| 73 | MP0003646_muscle_fatigue | 0.56876813 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.56825114 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 0.56625045 |
| 76 | MP0001984_abnormal_olfaction | 0.56250743 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.55662852 |
| 78 | MP0008874_decreased_physiological_sensi | 0.55307220 |
| 79 | MP0002249_abnormal_larynx_morphology | 0.55198674 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 0.53586607 |
| 81 | MP0003880_abnormal_central_pattern | 0.53005686 |
| 82 | MP0002102_abnormal_ear_morphology | 0.52749239 |
| 83 | MP0005248_abnormal_Harderian_gland | 0.52632863 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.51925904 |
| 85 | MP0005395_other_phenotype | 0.51151591 |
| 86 | MP0002653_abnormal_ependyma_morphology | 0.50744840 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.50291206 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.49405247 |
| 89 | MP0006035_abnormal_mitochondrial_morpho | 0.48833800 |
| 90 | MP0004133_heterotaxia | 0.48374998 |
| 91 | MP0003075_altered_response_to | 0.48016064 |
| 92 | MP0003718_maternal_effect | 0.47523613 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.46121312 |
| 94 | MP0003436_decreased_susceptibility_to | 0.45964812 |
| 95 | MP0005670_abnormal_white_adipose | 0.45649570 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.45321191 |
| 97 | MP0001968_abnormal_touch/_nociception | 0.45205918 |
| 98 | MP0006082_CNS_inflammation | 0.44572993 |
| 99 | MP0008873_increased_physiological_sensi | 0.44554019 |
| 100 | MP0003953_abnormal_hormone_level | 0.44321808 |
| 101 | MP0003136_yellow_coat_color | 0.44225500 |
| 102 | MP0006276_abnormal_autonomic_nervous | 0.43989153 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.43942710 |
| 104 | MP0000249_abnormal_blood_vessel | 0.42645157 |
| 105 | MP0009672_abnormal_birth_weight | 0.42518144 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.42026382 |
| 107 | MP0005253_abnormal_eye_physiology | 0.40820416 |
| 108 | MP0004883_abnormal_blood_vessel | 0.40748292 |
| 109 | MP0008872_abnormal_physiological_respon | 0.39546887 |
| 110 | MP0002064_seizures | 0.37681810 |
| 111 | MP0002168_other_aberrant_phenotype | 0.35628094 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.35610216 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.35543867 |
| 114 | MP0004924_abnormal_behavior | 0.35543867 |
| 115 | MP0001243_abnormal_dermal_layer | 0.34945058 |
| 116 | MP0003633_abnormal_nervous_system | 0.34810148 |
| 117 | MP0002736_abnormal_nociception_after | 0.34479672 |
| 118 | MP0003724_increased_susceptibility_to | 0.34243150 |
| 119 | MP0002928_abnormal_bile_duct | 0.33806444 |
| 120 | MP0009115_abnormal_fat_cell | 0.31584038 |
| 121 | MP0002970_abnormal_white_adipose | 0.31402204 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.30319025 |
| 123 | MP0001853_heart_inflammation | 0.29728402 |
| 124 | MP0005187_abnormal_penis_morphology | 0.28305431 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.27618628 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.27306629 |
| 127 | MP0005164_abnormal_response_to | 0.27057225 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.25112170 |
| 129 | MP0005166_decreased_susceptibility_to | 0.24387687 |
| 130 | MP0002090_abnormal_vision | 0.24382150 |
| 131 | MP0001881_abnormal_mammary_gland | 0.23918487 |
| 132 | MP0002269_muscular_atrophy | 0.23553798 |
| 133 | MP0002295_abnormal_pulmonary_circulatio | 0.20104397 |
| 134 | MP0005379_endocrine/exocrine_gland_phen | 0.17738812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.72248820 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.67764457 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.93045561 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.88769815 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.67559170 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.49896814 |
| 7 | Xanthomatosis (HP:0000991) | 6.32429511 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 6.16072190 |
| 9 | Joint hemorrhage (HP:0005261) | 5.08904624 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.97831097 |
| 11 | Hyperammonemia (HP:0001987) | 4.69524833 |
| 12 | Hyperglycinemia (HP:0002154) | 4.63397447 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.56711589 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29434215 |
| 15 | Ketosis (HP:0001946) | 4.28920056 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.28714353 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.27331668 |
| 18 | Epidermoid cyst (HP:0200040) | 4.24802872 |
| 19 | Hyperglycinuria (HP:0003108) | 4.23382199 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.20440908 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.20440908 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.19957314 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18485714 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06440483 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.92886574 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.88862803 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.84755714 |
| 28 | Fat malabsorption (HP:0002630) | 3.81349089 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78722107 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.64275277 |
| 31 | Complement deficiency (HP:0004431) | 3.58660511 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52342954 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.39070317 |
| 34 | Delayed CNS myelination (HP:0002188) | 3.36260522 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34306151 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28058106 |
| 37 | Ketoacidosis (HP:0001993) | 3.15549933 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.08217189 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07369081 |
| 40 | Fair hair (HP:0002286) | 3.07044125 |
| 41 | Vascular calcification (HP:0004934) | 3.01158321 |
| 42 | Myocardial infarction (HP:0001658) | 2.94548005 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.92683303 |
| 44 | Metabolic acidosis (HP:0001942) | 2.88228607 |
| 45 | Steatorrhea (HP:0002570) | 2.75661119 |
| 46 | Spontaneous abortion (HP:0005268) | 2.75246790 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.75077464 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.75077464 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.71692568 |
| 50 | Glomerulonephritis (HP:0000099) | 2.68968721 |
| 51 | Cardiovascular calcification (HP:0011915) | 2.68784337 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.67573157 |
| 53 | Lethargy (HP:0001254) | 2.65275637 |
| 54 | Skin nodule (HP:0200036) | 2.63725798 |
| 55 | Abnormality of complement system (HP:0005339) | 2.59970588 |
| 56 | Malnutrition (HP:0004395) | 2.56979266 |
| 57 | Mitral stenosis (HP:0001718) | 2.54369240 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.46233537 |
| 59 | Spastic diplegia (HP:0001264) | 2.45601706 |
| 60 | Acanthocytosis (HP:0001927) | 2.45401514 |
| 61 | Menorrhagia (HP:0000132) | 2.42215906 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.40075545 |
| 63 | Cerebral edema (HP:0002181) | 2.39013248 |
| 64 | Irritability (HP:0000737) | 2.37985276 |
| 65 | Amyloidosis (HP:0011034) | 2.32585802 |
| 66 | Cholelithiasis (HP:0001081) | 2.31208691 |
| 67 | Bile duct proliferation (HP:0001408) | 2.31117520 |
| 68 | Abnormal biliary tract physiology (HP:0012439) | 2.31117520 |
| 69 | Gout (HP:0001997) | 2.30060931 |
| 70 | Esophageal varix (HP:0002040) | 2.27677799 |
| 71 | Neonatal onset (HP:0003623) | 2.20744692 |
| 72 | Late onset (HP:0003584) | 2.20035995 |
| 73 | Arthropathy (HP:0003040) | 2.19624071 |
| 74 | Generalized hypopigmentation of hair (HP:0011358) | 2.19031602 |
| 75 | Purpura (HP:0000979) | 2.16835220 |
| 76 | Neonatal hypoglycemia (HP:0001998) | 2.14308255 |
| 77 | Glycosuria (HP:0003076) | 2.14238910 |
| 78 | Abnormality of urine glucose concentration (HP:0011016) | 2.14238910 |
| 79 | Vomiting (HP:0002013) | 2.12441761 |
| 80 | Pancreatitis (HP:0001733) | 2.09644673 |
| 81 | Gingival bleeding (HP:0000225) | 2.08222888 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.06934885 |
| 83 | Cholecystitis (HP:0001082) | 2.06934885 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.06804683 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.06804683 |
| 86 | Generalized aminoaciduria (HP:0002909) | 2.05991266 |
| 87 | Thrombophlebitis (HP:0004418) | 2.05515455 |
| 88 | Brushfield spots (HP:0001088) | 2.05161531 |
| 89 | Opisthotonus (HP:0002179) | 2.04181297 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.03633999 |
| 91 | Hyperalaninemia (HP:0003348) | 2.03633999 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.03633999 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.02994992 |
| 94 | Enlarged kidneys (HP:0000105) | 2.01657664 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99731853 |
| 96 | Poikilocytosis (HP:0004447) | 1.98609849 |
| 97 | Alkalosis (HP:0001948) | 1.96732937 |
| 98 | Hyperphosphaturia (HP:0003109) | 1.93694309 |
| 99 | Nephritis (HP:0000123) | 1.91646075 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 1.91408809 |
| 101 | Cerebral palsy (HP:0100021) | 1.90750624 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.90069359 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 1.89797555 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 1.86897436 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86643924 |
| 106 | Rickets (HP:0002748) | 1.86433327 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.86338316 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 1.85961938 |
| 109 | Hyperventilation (HP:0002883) | 1.85931247 |
| 110 | Gangrene (HP:0100758) | 1.82522564 |
| 111 | Decreased central vision (HP:0007663) | 1.81173085 |
| 112 | Pulmonary embolism (HP:0002204) | 1.80784053 |
| 113 | Status epilepticus (HP:0002133) | 1.79837719 |
| 114 | Renal cortical cysts (HP:0000803) | 1.78752724 |
| 115 | Chronic hepatic failure (HP:0100626) | 1.78375886 |
| 116 | Abnormality of the Achilles tendon (HP:0005109) | 1.77758933 |
| 117 | Congenital stationary night blindness (HP:0007642) | 1.77218386 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.76204914 |
| 119 | Hypothermia (HP:0002045) | 1.76022867 |
| 120 | Reticulocytosis (HP:0001923) | 1.75945537 |
| 121 | Osteomalacia (HP:0002749) | 1.74218262 |
| 122 | Stroke (HP:0001297) | 1.73335199 |
| 123 | Pancreatic cysts (HP:0001737) | 1.70583053 |
| 124 | Reduced antithrombin III activity (HP:0001976) | 1.70312742 |
| 125 | Increased serum ferritin (HP:0003281) | 1.67153120 |
| 126 | Blue irides (HP:0000635) | 1.60952989 |
| 127 | Joint swelling (HP:0001386) | 1.60636216 |
| 128 | Acute encephalopathy (HP:0006846) | 1.60214918 |
| 129 | Mesangial abnormality (HP:0001966) | 1.48907173 |
| 130 | Potter facies (HP:0002009) | 1.48447102 |
| 131 | Facial shape deformation (HP:0011334) | 1.48447102 |
| 132 | Abnormality of the renal cortex (HP:0011035) | 1.46233672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.45819942 |
| 2 | SIK1 | 5.34778472 |
| 3 | FGFR4 | 4.58781046 |
| 4 | ERN1 | 3.72662810 |
| 5 | PKN2 | 3.30160572 |
| 6 | ADRBK2 | 3.20078289 |
| 7 | MAP4K2 | 2.93791274 |
| 8 | TAOK3 | 2.92432657 |
| 9 | WNK3 | 2.74503610 |
| 10 | INSRR | 2.54397742 |
| 11 | BMPR1B | 2.52686419 |
| 12 | TLK1 | 2.36657935 |
| 13 | FLT3 | 2.33489091 |
| 14 | PIK3CG | 2.30711731 |
| 15 | MAP2K4 | 2.29168088 |
| 16 | TRIB3 | 2.27704782 |
| 17 | ZAK | 2.19585172 |
| 18 | DAPK2 | 2.19468308 |
| 19 | WNK4 | 2.03763168 |
| 20 | ACVR1B | 1.98641943 |
| 21 | MST1R | 1.91678762 |
| 22 | TYK2 | 1.84258296 |
| 23 | NUAK1 | 1.73583213 |
| 24 | PTK6 | 1.60823671 |
| 25 | TXK | 1.54070096 |
| 26 | KDR | 1.53705835 |
| 27 | MAPK13 | 1.51640993 |
| 28 | ABL2 | 1.44875514 |
| 29 | NTRK3 | 1.39028807 |
| 30 | PIK3CA | 1.36007539 |
| 31 | DYRK2 | 1.35000588 |
| 32 | FGFR2 | 1.33167378 |
| 33 | CASK | 1.29753443 |
| 34 | LATS1 | 1.28016522 |
| 35 | CAMKK2 | 1.26936232 |
| 36 | ERBB4 | 1.23486401 |
| 37 | MAP3K4 | 1.22950698 |
| 38 | PINK1 | 1.17969419 |
| 39 | MAPKAPK3 | 1.17139253 |
| 40 | TNK2 | 1.14985495 |
| 41 | MAPK11 | 1.14510633 |
| 42 | FRK | 1.13946677 |
| 43 | ADRBK1 | 1.13073171 |
| 44 | JAK2 | 1.12211433 |
| 45 | MUSK | 1.08232602 |
| 46 | MAP2K3 | 1.07186236 |
| 47 | TNIK | 1.05891871 |
| 48 | PRKAA2 | 1.04843445 |
| 49 | TBK1 | 1.00876055 |
| 50 | MAPK4 | 0.99213593 |
| 51 | IKBKB | 0.98779154 |
| 52 | GRK6 | 0.97404664 |
| 53 | JAK1 | 0.96745682 |
| 54 | MAP3K7 | 0.95235613 |
| 55 | EPHA4 | 0.92897251 |
| 56 | PRKCZ | 0.91450580 |
| 57 | OXSR1 | 0.91212582 |
| 58 | NEK9 | 0.88900229 |
| 59 | TIE1 | 0.88105384 |
| 60 | MAP3K11 | 0.87175794 |
| 61 | CDK6 | 0.86803417 |
| 62 | MAP3K10 | 0.86155660 |
| 63 | EPHB1 | 0.85345971 |
| 64 | CSK | 0.84426722 |
| 65 | DYRK1B | 0.84097841 |
| 66 | PRKCE | 0.83457578 |
| 67 | MAPK12 | 0.82704306 |
| 68 | MAP3K14 | 0.79442783 |
| 69 | KIT | 0.78636236 |
| 70 | MET | 0.77460586 |
| 71 | PRKACG | 0.76012688 |
| 72 | PRKG1 | 0.70501917 |
| 73 | MAP3K3 | 0.70090402 |
| 74 | CSNK1G1 | 0.69745517 |
| 75 | MAP2K7 | 0.68699853 |
| 76 | TGFBR1 | 0.68240250 |
| 77 | VRK1 | 0.67660486 |
| 78 | RIPK1 | 0.67325630 |
| 79 | GSK3A | 0.66792618 |
| 80 | CHUK | 0.65191816 |
| 81 | TGFBR2 | 0.65097989 |
| 82 | CAMK1D | 0.64983603 |
| 83 | PTK2 | 0.64472761 |
| 84 | MAP4K1 | 0.64453972 |
| 85 | RPS6KA5 | 0.64230143 |
| 86 | MAP2K6 | 0.63341315 |
| 87 | PKN1 | 0.63142436 |
| 88 | AKT3 | 0.62550292 |
| 89 | FER | 0.62182626 |
| 90 | GRK7 | 0.60847360 |
| 91 | CSF1R | 0.60389678 |
| 92 | SIK2 | 0.60110597 |
| 93 | CSNK1A1 | 0.59799764 |
| 94 | PRKCQ | 0.59525050 |
| 95 | NLK | 0.58854284 |
| 96 | PRKAA1 | 0.58552365 |
| 97 | MARK1 | 0.58383657 |
| 98 | CSNK1D | 0.58352965 |
| 99 | SGK3 | 0.58248832 |
| 100 | CSNK1G3 | 0.57740824 |
| 101 | MAP3K13 | 0.57382684 |
| 102 | RET | 0.57298213 |
| 103 | PDPK1 | 0.55453522 |
| 104 | CSNK1G2 | 0.55451687 |
| 105 | MAPK15 | 0.53893759 |
| 106 | STK16 | 0.53509654 |
| 107 | STK38L | 0.52666726 |
| 108 | MAPKAPK5 | 0.52247683 |
| 109 | ERBB2 | 0.51547710 |
| 110 | DYRK1A | 0.51400839 |
| 111 | SYK | 0.49613985 |
| 112 | MAPK7 | 0.49465714 |
| 113 | PRKCG | 0.49246966 |
| 114 | CSNK1A1L | 0.47586672 |
| 115 | PHKG1 | 0.45397523 |
| 116 | PHKG2 | 0.45397523 |
| 117 | CAMKK1 | 0.44557832 |
| 118 | STK39 | 0.44429182 |
| 119 | GRK1 | 0.43792098 |
| 120 | TEC | 0.43676395 |
| 121 | CAMK2G | 0.43462048 |
| 122 | IKBKE | 0.43300125 |
| 123 | SGK2 | 0.43195181 |
| 124 | PDK1 | 0.43192946 |
| 125 | MAP2K1 | 0.42537478 |
| 126 | CAMK2A | 0.41843588 |
| 127 | IGF1R | 0.41386666 |
| 128 | EPHA3 | 0.41074265 |
| 129 | CSNK2A1 | 0.40563292 |
| 130 | MAP3K6 | 0.39778748 |
| 131 | FGFR3 | 0.39675715 |
| 132 | TAOK2 | 0.39303662 |
| 133 | CDK4 | 0.38715758 |
| 134 | SGK223 | 0.37857390 |
| 135 | SGK494 | 0.37857390 |
| 136 | ICK | 0.37166213 |
| 137 | PRKCB | 0.36483112 |
| 138 | LYN | 0.36336760 |
| 139 | PDK2 | 0.36306919 |
| 140 | LATS2 | 0.36136257 |
| 141 | PRKACB | 0.34754523 |
| 142 | BRSK2 | 0.33528708 |
| 143 | CAMK4 | 0.31424037 |
| 144 | MTOR | 0.29976799 |
| 145 | MAP3K1 | 0.27368787 |
| 146 | KSR2 | 0.26433891 |
| 147 | PAK3 | 0.26431259 |
| 148 | MAP3K5 | 0.26229183 |
| 149 | PRKCA | 0.25504237 |
| 150 | PBK | 0.24311490 |
| 151 | BLK | 0.23314973 |
| 152 | RPS6KA3 | 0.21349367 |
| 153 | PDK4 | 0.21070941 |
| 154 | PDK3 | 0.21070941 |
| 155 | MAP2K2 | 0.20845448 |
| 156 | FGFR1 | 0.20503736 |
| 157 | PRKACA | 0.20096988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99772076 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.73956328 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.72606769 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21295720 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.01491340 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99991597 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66924156 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55551982 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49637555 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46829784 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46549133 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.44056247 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41445143 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.37197291 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22795525 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.17502447 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.14847976 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00610251 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99886131 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98932619 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.96056266 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.92133042 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84100181 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83892918 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82805501 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78153163 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77352086 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76747277 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75731312 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61074402 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60885211 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56255390 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55423469 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.53964104 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48599385 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48200122 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45817032 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39749926 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35715719 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33315244 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28702221 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24258086 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24008997 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17049353 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.16861270 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15369233 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14171284 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11531877 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10879344 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04458884 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03836120 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92506707 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88883386 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87497936 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87325570 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82571262 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.80466537 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77144490 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75605647 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70553061 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68292837 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59086134 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58164434 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55429768 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54652076 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44569407 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44347389 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39181138 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33137226 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29291141 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28927902 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.27063231 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25448794 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24314118 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.24044286 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20688002 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.20643410 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20619902 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19582762 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19151313 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16950819 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15147217 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12213377 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.09879779 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.06289889 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.05788991 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05356657 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.00860602 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2552304 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2496747 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2484876 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2447917 |
| 93 | Pertussis_Homo sapiens_hsa05133 | -0.2443373 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.2386614 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2330748 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2285940 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2166738 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1997861 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1954701 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1905425 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1851091 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1760365 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1652026 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1615114 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1383111 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1198217 |
| 107 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1034101 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0835507 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0653778 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | -0.0518051 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0425466 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0372147 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0359161 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0095041 |
| 115 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0044350 |

